SpineGuard SA
EPA:ALSGD.PA
0.22 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.313 | 5.6 | 4.405 | 4.852 | 6.829 | 7.575 | 8.174 | 7.463 | 6.228 | 4.361 | 4.615 | 3.877 | 3.004 |
| Cost of Revenue
| 0.934 | 1.084 | 0.978 | 0.981 | 1.061 | 1.022 | 1.222 | 1.109 | 0.863 | 0.582 | 0.588 | 0.531 | 0.305 |
| Gross Profit
| 3.379 | 4.516 | 3.427 | 3.871 | 5.768 | 6.553 | 6.952 | 6.354 | 5.365 | 3.779 | 4.027 | 3.346 | 2.699 |
| Gross Profit Ratio
| 0.783 | 0.806 | 0.778 | 0.798 | 0.845 | 0.865 | 0.851 | 0.851 | 0.861 | 0.866 | 0.873 | 0.863 | 0.899 |
| Reseach & Development Expenses
| 1.433 | 1.108 | 0.885 | 0.815 | 0.874 | 1.123 | 1.483 | 1.54 | 1.076 | 1.136 | 1.016 | 0.588 | 0.387 |
| General & Administrative Expenses
| 0.908 | 1.658 | 1.394 | 1.74 | 1.855 | 1.853 | 2.116 | 2.049 | 1.968 | 1.907 | 1.607 | 1.004 | 0.837 |
| Selling & Marketing Expenses
| 1.801 | 3.7 | 2.66 | 2.578 | 3.5 | 4.84 | 6.116 | 6.643 | 6.514 | 5.416 | 4.761 | 2.36 | 1.797 |
| SG&A
| 2.709 | 5.22 | 3.925 | 4.201 | 5.355 | 6.694 | 8.232 | 8.692 | 8.482 | 7.323 | 6.368 | 3.364 | 2.635 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.583 | 2.288 |
| Operating Expenses
| 7.299 | 6.328 | 4.811 | 5.016 | 6.003 | 7.799 | 10.256 | 9.872 | 9.022 | 8.013 | 7.264 | 6.535 | 5.31 |
| Operating Income
| -3.976 | -1.812 | -1.384 | -1.146 | -0.311 | -1.073 | -2.547 | -3.633 | -3.974 | -4.479 | -3.153 | -3.189 | -2.611 |
| Operating Income Ratio
| -0.922 | -0.324 | -0.314 | -0.236 | -0.046 | -0.142 | -0.312 | -0.487 | -0.638 | -1.027 | -0.683 | -0.823 | -0.869 |
| Total Other Income Expenses Net
| -0.225 | -0.276 | -0.265 | -1.534 | -0.763 | -1.243 | -1.579 | -0.545 | 0.096 | -0.06 | -0.362 | -0.076 | 0.044 |
| Income Before Tax
| -4.201 | -2.089 | -1.649 | -2.68 | -1.075 | -2.315 | -4.125 | -4.178 | -3.878 | -4.539 | -3.515 | -3.266 | -2.567 |
| Income Before Tax Ratio
| -0.974 | -0.373 | -0.374 | -0.552 | -0.157 | -0.306 | -0.505 | -0.56 | -0.623 | -1.041 | -0.762 | -0.842 | -0.855 |
| Income Tax Expense
| -0.018 | 0.305 | 0.076 | 0.037 | 0.389 | 0.019 | -0.216 | -0.245 | 0 | 0 | 0 | 0.076 | -0.044 |
| Net Income
| -4.183 | -2.393 | -1.725 | -2.716 | -0.686 | -2.334 | -4.125 | -4.178 | -3.878 | -4.539 | -3.515 | -3.266 | -2.567 |
| Net Income Ratio
| -0.97 | -0.427 | -0.392 | -0.56 | -0.1 | -0.308 | -0.505 | -0.56 | -0.623 | -1.041 | -0.762 | -0.842 | -0.855 |
| EPS
| -0.11 | -0.074 | -0.062 | -0.13 | -0.072 | -0.37 | -0.75 | -0.83 | -0.82 | -1.04 | -0.89 | -1.08 | -1 |
| EPS Diluted
| -0.11 | -0.074 | -0.062 | -0.13 | -0.072 | -0.37 | -0.75 | -0.83 | -0.82 | -1.04 | -0.89 | -1.08 | -1 |
| EBITDA
| -3.497 | -1.52 | -1.076 | -0.794 | -0.207 | -0.959 | -2.414 | -3.508 | -3.874 | -4.386 | -3.039 | -3.061 | -2.448 |
| EBITDA Ratio
| -0.811 | -0.271 | -0.244 | -0.164 | -0.03 | -0.127 | -0.295 | -0.47 | -0.622 | -1.006 | -0.658 | -0.79 | -0.815 |